Storico di ricavi, utili e flussi di cassa dai bilanci ufficiali.
Nordson Corporation progetta, produce e commercializza prodotti e sistemi per erogare, applicare e controllare adesivi, rivestimenti, polimeri, sigillanti, biomateriali, componenti medici e altri fluidi.
Tradotto automaticamente
Vedi grafici interattivi e bilanci completi → Modello di valutazione (DCF) →
| Conto economico | TTM → 2026-07-31 | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | 2020-10-31 | 2019-10-31 | 2018-10-31 | 2017-10-31 | 2016-10-31 | 2015-10-31 | 2014-10-31 | 2013-10-31 | 2012-10-31 | 2011-10-31 | 2010-10-31 | 2009-10-31 | 2008-10-31 | 2007-10-31 | 2006-10-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Entrate totali | $3.0B | $2.8B | $2.7B | $2.6B | $2.6B | $2.4B | $2.1B | $2.2B | $2.3B | $2.1B | $1.8B | $1.7B | $1.7B | $1.5B | $1.4B | $1.2B | $1.0B | $819M | $1.1B | $994M | $892M |
| Utile lordo | $1.6B | $1.5B | $1.5B | $1.4B | $1.4B | $1.3B | $1.1B | $1.2B | $1.2B | $1.1B | $993M | $914M | $945M | $866M | $823M | $748M | $622M | $469M | $630M | $554M | $512M |
| Margine lordo% | 55.3% | 55.2% | 55.2% | 54.2% | 55.1% | 56.0% | 53.3% | 54.3% | 54.8% | 55.1% | 54.9% | 54.1% | 55.5% | 56.1% | 58.4% | 60.7% | 59.7% | 57.2% | 56.0% | 55.7% | 57.4% |
| Risultato Operativo (EBIT) | $801M | $724M | $674M | $673M | $702M | $615M | $350M | $483M | $503M | $466M | $388M | $318M | $367M | $324M | $335M | $316M | $235M | ($128M) | $190M | $152M | $148M |
| Margine operativo % | 26.9% | 25.9% | 25.1% | 25.6% | 27.1% | 26.0% | 16.5% | 22.0% | 22.3% | 22.6% | 21.5% | 18.8% | 21.5% | 21.0% | 23.8% | 25.6% | 22.6% | -15.6% | 16.9% | 15.3% | 16.5% |
| Reddito netto | $555M | $484M | $467M | $487M | $513M | $454M | $250M | $337M | $377M | $296M | $272M | $211M | $247M | $222M | $225M | $222M | $168M | ($160M) | $118M | $91M | $91M |
| Margine netto% | 18.6% | 17.3% | 17.4% | 18.6% | 19.8% | 19.2% | 11.8% | 15.4% | 16.7% | 14.3% | 15.0% | 12.5% | 14.5% | 14.4% | 16.0% | 18.0% | 16.1% | -19.5% | 10.4% | 9.1% | 10.2% |
| EBITDA | $947M | $849M | $811M | $787M | $772M | $704M | $447M | $588M | $607M | $548M | $460M | $384M | $427M | $380M | $376M | $344M | $264M | ($88M) | $229M | $185M | $177M |
| Utile per azione (EPS) | $9.88 | $8.51 | $8.11 | $8.46 | $8.81 | $7.74 | $4.27 | $5.79 | $6.40 | $5.08 | $4.73 | $3.45 | $3.84 | $3.42 | $3.45 | $3.31 | $2.46 | $-2.38 | $1.71 | $1.33 | $1.33 |
| Azioni in circolazione (M) | 56M | 57M | 58M | 58M | 58M | 59M | 58M | 58M | 59M | 58M | 58M | 61M | 64M | 65M | 65M | 67M | 68M | 67M | 69M | 68M | 68M |
Fonte: bilanci pubblici della società (SEC). Verificare su SEC EDGAR prima di fare affidamento su qualsiasi cifra.
Stati patrimoniali, flussi di cassa, dati trimestrali e indici completi nel visualizzatore interattivo di NDSN. /companies/us/NDSN
Le informazioni di questo sito sono solo a scopo educativo e informativo; non costituiscono consulenza finanziaria. Non vengono pubblicati prezzi obiettivo né raccomandazioni.
About TickerBase · Data methodology & sources · Privacy · Terms